Search

Your search keyword '"Wen, Jing-Yun"' showing total 6 results
Start Over Author "Wen, Jing-Yun" Journal oncology letters
6 results on '"Wen, Jing-Yun"'

1. Comparison of five staging systems in predicting the survival rate of patients with hepatocellular carcinoma undergoing trans‑arterial chemoembolization therapy

Author

Chen, Zhan‑Hong, primary, Hong, Ying‑Fen, additional, Chen, Xiangwei, additional, Chen, Jie, additional, Lin, Qu, additional, Lin, Jinxiang, additional, Li, Xing, additional, Wen, Jing‑Yun, additional, Ruan, Dan‑Yun, additional, Dong, Min, additional, Wei, Li, additional, Wang, Tian‑Tian, additional, Lin, Ze‑Xiao, additional, Ma, Xiao‑Kun, additional, Wu, Dong‑Hao, additional, Wu, Xiang‑Yuan, additional, and Xu, Ruihua, additional

Published
2017
Full Text
View/download PDF

2. Serum Golgi protein 73 is a prognostic rather than diagnostic marker in hepatocellular carcinoma

Author

Dong, Min, primary, Chen, Zhan‑Hong, additional, Li, Xing, additional, Li, Xiao‑Yun, additional, Wen, Jing‑Yun, additional, Lin, Qu, additional, Ma, Xiao‑Kun, additional, Wei, Li, additional, Chen, Jie, additional, Ruan, Dan‑Yun, additional, Lin, Ze‑Xiao, additional, Wang, Tian‑Tian, additional, Wu, Dong‑Hao, additional, and Wu, Xiang‑Yuan, additional

Published
2017
Full Text
View/download PDF

3. Identification of the prognostic value of lymphocyte-to-monocyte ratio in patients with HBV-associated advanced hepatocellular carcinoma

Author

Hong, Ying-Fen, primary, Chen, Zhan-Hong, additional, Wei, Li, additional, Ma, Xiao-Kun, additional, Li, Xing, additional, Wen, Jing-Yun, additional, Wang, Tian-Tian, additional, Cai, Xiu-Rong, additional, Wu, Dong-Hao, additional, Chen, Jie, additional, Ruan, Dan-Yun, additional, Lin, Ze-Xiao, additional, Lin, Qu, additional, Dong, Min, additional, and Wu, Xiang-Yuan, additional

Published
2017
Full Text
View/download PDF

4. Validation and ranking of seven staging systems of hepatocellular carcinoma

Author

Chen, Zhan-Hong, primary, Hong, Ying-Fen, additional, Lin, Jinxiang, additional, Li, Xing, additional, Wu, Dong-Hao, additional, Wen, Jing-Yun, additional, Chen, Jie, additional, Ruan, Dan-Yun, additional, Lin, Qu, additional, Dong, Min, additional, Wei, Li, additional, Wang, Tian-Tian, additional, Lin, Ze-Xiao, additional, Ma, Xiao-Kun, additional, Wu, Xiang-Yuan, additional, and Xu, Ruihua, additional

Published
2017
Full Text
View/download PDF

5. Comparison of five staging systems in predicting the survival rate of patients with hepatocellular carcinoma undergoing trans-arterial chemoembolization therapy.

Author

Chen, Zhan-Hong, Hong, Ying-Fen, Chen, Xiangwei, Chen, Jie, Lin, Qu, Lin, Jinxiang, Li, Xing, Wen, Jing-Yun, Ruan, Dan-Yun, Dong, Min, Wei, Li, Wang, Tian-Tian, Lin, Ze-Xiao, Ma, Xiao-Kun, Wu, Dong-Hao, Wu, Xiang-Yuan, and Xu, Ruihua

Subjects
LIVER cancer patients, SURVIVAL analysis (Biometry), CHEMOEMBOLIZATION, LIVER cancer, PROGNOSIS
Abstract

The majority of patients with unresectable hepatocellular carcinoma (HCC) undergo trans-arterial chemoembolization (TACE). However, the prognosis of HCC remains poor. In the present study, five staging systems were compared to predict the survival rate of patients with HCC undergoing TACE treatment. A total of 220 patients with HCC were examined according to the model to estimate survival for hepatocellular carcinoma (MESH), hepatoma arterial embolization prognostic score (HAP), modified HAP (mHAP), performance status combined Japan Integrated Staging system (PSJIS) and tumor-node-metastasis (TNM) staging systems. The endpoints of the study were 3-month survival, 6-month survival, 1-year survival and overall survival (OS) rates. Receiver operating characteristic curve analysis indicated that the area under the curve of MESH, HAP, mHAP, PSJIS and TNM was 0.858, 0.728, 0.690, 0.688 and 0.699, respectively, in predicting 3-month survival rates; 0.822, 0.747, 0.720, 0.722 and 0.715, respectively, in predicting 6-month survival rates and 0.725, 0.664, 0.672, 0.645 and 0.654, respectively, in predicting 1-year survival rates. Discriminatory ability, homogeneity, monotonicity and prognostic stratification ability was evaluated using a likelihood ratio test and Akaike information criterion values among the five staging systems, and revealed that the MESH system was the optimal prognostic staging system for HCC. In conclusion, the results of the present study suggest that the MESH system is the most accurate prognostic staging system of 3-month survival, 6-month survival, 1-year survival and OS rates among the five systems analyzed in patients with HCC who have received TACE treatment. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

6. MicroRNA-34a-5p enhances sensitivity to chemotherapy by targeting AXL in hepatocellular carcinoma MHCC-97L cells

Author

LI, XIAO-YUN, primary, WEN, JING-YUN, additional, JIA, CHANG-CHANG, additional, WANG, TIAN-TIAN, additional, LI, XING, additional, DONG, MIN, additional, LIN, QU, additional, CHEN, ZHAN-HONG, additional, MA, XIAO-KUN, additional, WEI, LI, additional, LIN, ZE-XIAO, additional, RUAN, DAN-YUN, additional, CHEN, JIE, additional, WU, DONG-HAO, additional, LIU, WEI, additional, TAI, YAN, additional, XIONG, ZHI-YONG, additional, WU, XIANG-YUAN, additional, and ZHANG, QI, additional

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results